课题基金 / 基金详情

CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - MALE

CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - MALE
CCTN - 避孕临床试验网络 - 核心 - 男性
批准号：
9571111
负责人：
CHRISTINA WANG
金额：
$5.1万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-09-27 至 2018-09-26
来源：
https://reporter.nih.gov/project-details/9571111
关键词：
Adverse effectsClinical Trials NetworkConduct Clinical TrialsContraceptive AgentsContraceptive methodsDevelopmentFutureGoalsMedicalMethodsMissionNational Institute of Child Health and Human DevelopmentProtocols documentationRiskServicesmalemenproduct developmentprotocol developmentunintended pregnancy

项目摘要

项目成果

CHRISTINA WANG的其他基金

相似基金

相关文献

中文摘要
翻译
人们需要为男性提供有效保护的新的避孕方法。 意外怀孕以及减少副作用的风险。CCTN的使命是 制定方案并进行临床试验，以帮助最终完成产品开发 目标是为男性提供有效和安全的避孕措施。 尤尼斯·肯尼迪·施莱弗国家儿童健康和人类发展研究所 (NICHD)的使命是为以下男性开发安全有效的避孕药具 有现行避孕药禁忌使用的医疗条件。
英文摘要
There is a demand for new methods of contraception for men that can provide effective protection against unintended pregnancy as well as reduce the risk of side effects. The mission of the CCTN is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for men. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for men who have medical conditions for which current contraceptive products are contraindicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE
海外基金